Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -148.27x is 11% above its 1-year average of -165.83x, near the high end of its 1-year range (-409.05x–-81.06x).
As of the fiscal period ended Thursday, December 31, 2020. 10.59% above its 12-month average of -165.83x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2020 (2020-12-31): -148.27x.
INTEREST COVERAGE RATIO
-148.27x
INTEREST COVERAGE RATIO AVG TTM
-165.83x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+10.59%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-2202.29%
vs the sector median at left
Protagonist Therapeutics, Inc.
Market Cap
$8.92B
Interest Coverage Ratio
-148.27x
TTM Avg
-165.83x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.93B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$8.97B
Interest Coverage Ratio
-25.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.72B
Interest Coverage Ratio
-1403.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.67B
Interest Coverage Ratio
1.10x
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$9.21B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$9.33B
Interest Coverage Ratio
5.94x
TTM Avg
6.59x
3Y Avg
5.07x
5Y Avg
3.90x
Market Cap
$8.38B
Interest Coverage Ratio
-22.52x
TTM Avg
2.41x
3Y Avg
2.41x
5Y Avg
2.41x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc. (PTGX) | $8.92B | -148.27x | -165.83x | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $8.93B | 3.91x | 4.60x | 15.68x | 18.14x |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.97B | -25.81x | N/A | N/A | N/A |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.72B | -1403.21x | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.67B | 1.10x | 1.10x | 1.10x | 1.10x |
| Bruker Corporation (BRKR)vs › | $9.21B | 3.91x | 4.60x | 15.68x | 18.14x |
| Insulet Corp. (PODD)vs › | $9.33B | 5.94x | 6.59x | 5.07x | 3.90x |
| Oscar Health, Inc. (OSCR)vs › | $8.38B | -22.52x | 2.41x | 2.41x | 2.41x |
| Vaxcyte, Inc. (PCVX)vs › | $9.63B | N/A | N/A | N/A | N/A |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | N/A | N/A | N/A | N/A |
Interest Coverage
-148.3x
Debt/Equity
0.01
Current Ratio
21.71
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-12-31 | -148.27x |
| 2020-09-30 | -409.05x |
| 2020-06-30 | -87.16x |
| 2020-03-31 | -81.06x |
| 2019-12-31 | -103.59x |
